Data relating to traceability collected in the context of studies into ATMPs is subject to a retention period of at least 30 years in accordance with Article 6.37 of the Guidelines on Good Manufacturing Practice specific to Advanced Therapy Medicinal Products. What data is meant here? Does this only concern manufacturing data or all clinical trial data?